Hidden Protein Brake on Plaques Reveals New Path Beyond Cholesterol
Researchers in Shanghai have discovered that the protein TXNIP suppresses dangerous plaque angiogenesis by degrading the glycolytic enzyme HK2 and ...
Researchers in Shanghai have discovered that the protein TXNIP suppresses dangerous plaque angiogenesis by degrading the glycolytic enzyme HK2 and ...
A systematic review and meta-analysis of 17 studies finds that the ANGPTL3-blocking antibody evinacumab cuts LDL cholesterol by roughly half ...
A landmark cohort study of 7.5 million adults in northwestern China shows that metabolic abnormalities pose their greatest cardiovascular threat ...
A Norwegian study of adults with severe mental illness finds cardiovascular risk nearly double that of the general population, even ...
A parallel analysis of the UK Biobank and CHARLS cohorts reveals that males face higher cardiovascular disease risk across early ...
A baseline analysis of the INNOPREV trial finds that Italians at moderate-to-high cardiovascular risk perceive their risk as only moderate, ...
Exit interviews with 74 long-term participants in the SURPASS-CVOT trial reveal that tirzepatide and dulaglutide produced perceived benefits in glycemic ...
A new New York State study finds that when flooding and power outages occur together, cardiovascular hospitalization risk rises more ...
A UK Biobank study of over 52,000 adults found that accelerated biological aging mediates a substantial portion of the link ...
Researchers repurposed the approved drugs talazoparib, tivozanib and isradipine as candidate inhibitors of VAV2 signaling that reduced oxidized LDL uptake ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine